301263 logo

Guangdong Taienkang Pharmaceutical XSEC:301263 Stock Report

Last Price

CN¥12.93

Market Cap

CN¥5.5b

7D

0.5%

1Y

-34.7%

Updated

24 Jun, 2024

Data

Company Financials

Guangdong Taienkang Pharmaceutical Co., Ltd.

XSEC:301263 Stock Report

Market Cap: CN¥5.5b

301263 Stock Overview

Guangdong Taienkang Pharmaceutical Co., Ltd.

301263 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Guangdong Taienkang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangdong Taienkang Pharmaceutical
Historical stock prices
Current Share PriceCN¥12.93
52 Week HighCN¥23.99
52 Week LowCN¥11.65
Beta-0.18
11 Month Change-8.49%
3 Month Change-4.29%
1 Year Change-34.66%
33 Year Changen/a
5 Year Changen/a
Change since IPO-38.59%

Recent News & Updates

Recent updates

Shareholder Returns

301263CN PharmaceuticalsCN Market
7D0.5%-2.7%-1.9%
1Y-34.7%-12.7%-15.8%

Return vs Industry: 301263 underperformed the CN Pharmaceuticals industry which returned -12.7% over the past year.

Return vs Market: 301263 underperformed the CN Market which returned -15.8% over the past year.

Price Volatility

Is 301263's price volatile compared to industry and market?
301263 volatility
301263 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 301263 has not had significant price volatility in the past 3 months.

Volatility Over Time: 301263's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999931Hanjie Zhengwww.tai-kang.com.cn

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and daily cotton swabs, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs.

Guangdong Taienkang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Guangdong Taienkang Pharmaceutical's earnings and revenue compare to its market cap?
301263 fundamental statistics
Market capCN¥5.48b
Earnings (TTM)CN¥153.68m
Revenue (TTM)CN¥756.11m

34.4x

P/E Ratio

7.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301263 income statement (TTM)
RevenueCN¥756.11m
Cost of RevenueCN¥305.78m
Gross ProfitCN¥450.32m
Other ExpensesCN¥296.64m
EarningsCN¥153.68m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.36
Gross Margin59.56%
Net Profit Margin20.33%
Debt/Equity Ratio11.3%

How did 301263 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

81%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.